EU Medical Device Committee may play role in regulation of combination products
This article was originally published in RAJ Devices
Providing an opinion on the suggested qualification of combination/borderline products is one of the roles that the European Commission is considering for the new statutory Medical Devices Committee (MDC) that it is proposing as part of the recast of the medical device directives.
You may also be interested in...
Interview: Bassil Akra Speaks About Leaving TÜV-SÜD, Future Challenges, Opportunities And COVID-19 Realities
As Bassil Akra returned his office equipment and access card to his TÜV-SÜD offices in Munich amidst a welcome of balloons, Medtech Insight asked what this meant for him personally and what it will be like to start in consultancy during a pandemic.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR – How To Survive Changing And Confusing Times
26 May 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.
National authorities can renew notified body designations by conducting reviews that do not include on-site visits, overturning one of the most critical measures introduced in medical device regulations over the last seven years.